Please Wait
Applying Filters...
menu
    • menu
    Excipient Market Overview: Roquette announces restructuring post IFF Pharma buyout; WHO, FDA advance regulatory frameworks

    Data Compilation
    #PharmaFlow

    Pipeline Prospector May 2025: Pfizer strikes US$ 6 bn oncology pact; Lilly diversifies pipeline with US$ 2.3 bn in deals

    Stock Recap
    #PipelineProspector

    Menu

    Linagliptin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,605Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to access your PharmaMiles and download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    28/03/2025 Honour Lab
    India
    		 Otran Pharm Korea Co., Ltd. No. 4579-15-ND(2) Linagliptin 2019-02-01 Honour Lab Limited(Unit-III) India Plot No.4, Hetero Infrastructure SEZ Ltd., N.Narsapuram Village, Nakkapally Mandal, Visakhapatnam-District-531081, Andhara Pradesh, India
    28/03/2025 Polpharma
    Poland
    		 Aging Life Science Co., Ltd. Su434-8-ND Linagliptin 2019-01-11 Pharmaceutical Works Polpharma S.A. Poland 19 Pelplinska Street, 83-200 Starogard Gdanski, Poland
    OSZAR »